Adamant Biomedical Investments’s UnitedHealth UNH Stock Holding History

Adamant Biomedical Investments’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$11.6M	Sell	115,000 -13,000	-10%	-$1.23M	2.78%	6
2014 Q3	$11M	Buy	+128,000	New	+$10.8M	2.76%	7

Other funds holding UNH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Adamant Biomedical Investments's UNH Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its UnitedHealth (UNH) stake by 10% in Q4 2014, selling an estimated $1.23M and leaving 115,000 shares worth $11.6M. The position accounts for 2.78% of the portfolio, ranked #6.

Adamant Biomedical Investments first reported a position in UNH in Q3 2014 and has held it in 2 quarters since. 1,109 funds tracked by Wall St. Rank hold UNH as of Q4 2014.

Adamant Biomedical Investments held 115,000 shares of UnitedHealth worth $11.6M as of Q4 2014.
Adamant Biomedical Investments sold 13,000 UnitedHealth shares in Q4 2014, an estimated $1.23M.
UnitedHealth made up 2.78% of Adamant Biomedical Investments's portfolio in Q4 2014, its #6 holding.
Adamant Biomedical Investments first reported a position in UnitedHealth in Q3 2014 and has held it in 2 quarters since.
1,109 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.